α-Synuclein immunoreactivity in dementia with Lewy bodies:: morphological staging and comparison with ubiquitin immunostaining

被引:138
作者
Gómez-Tortosa, E
Newell, K
Irizarry, MC
Sanders, JL
Hyman, BT
机构
[1] Massachusetts Gen Hosp East, Alzheimers Res Unit, Charlestown, MA 02129 USA
[2] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA
关键词
Lewy bodies; alpha-synuclein; ubiquitin; dementia; Parkinson's disease;
D O I
10.1007/s004010051135
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
alpha-Synuclein is a presynaptic protein recently identified as a specific component of Lewy bodies (LB) and Lewy neurites. The aim of this study was to assess the morphology and distribution of alpha-synuclein immunoreactivity in cases of dementia with LB (DLB), and to compare alpha-synuclein with ubiquitin immunostaining. We examined substantia nigra, paralimbic regions (entorhinal cortex, cingulate gyrus, insula and hippocampus), and neocortex (frontal and occipital association cortices) with double alpha-synuclein and ubiquitin immunostaining in 25 cases meeting neuropathological criteria for DLB. alpha-Synuclein immunostaining was more specific than ubiquitin immunostaining in that it differentiated LB from globose tangles. It was also slightly more sensitive, staining 4-5% more intracytoplasmic structures, especially diffuse alpha-synuclein deposits that were ubiquitin negative. In addition to LB, alpha-synuclein staining showed filiform and globose neurites in the substantia nigra, CA2-3 regions of the hippocampus, and entorhinal cortex. A spectrum of alpha-synuclein staining was seen in substantia nigra: from diffuse "cloud-like" inclusions to aggregated intracytoplasmic inclusions with variable ubiquitin staining to classic LB. We hypothesize that these represent different stages in LB formation.
引用
收藏
页码:352 / 357
页数:6
相关论文
共 29 条
[1]  
Baba M, 1998, AM J PATHOL, V152, P879
[2]   AN ANTIGENIC PROFILE OF LEWY BODIES - IMMUNOCYTOCHEMICAL INDICATION FOR PROTEIN-PHOSPHORYLATION AND UBIQUITINATION [J].
BANCHER, C ;
LASSMANN, H ;
BUDKA, H ;
JELLINGER, K ;
GRUNDKEIQBAL, I ;
IQBAL, K ;
WICHE, G ;
SEITELBERGER, F ;
WISNIEWSKI, HM .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1989, 48 (01) :81-93
[3]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[4]   The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease [J].
Clayton, DF ;
George, JM .
TRENDS IN NEUROSCIENCES, 1998, 21 (06) :249-254
[5]   RELATIONSHIPS BETWEEN LEWY BODIES AND PALE BODIES IN PARKINSONS-DISEASE [J].
DALE, GE ;
PROBST, A ;
LUTHERT, P ;
MARTIN, J ;
ANDERTON, BH ;
LEIGH, PN .
ACTA NEUROPATHOLOGICA, 1992, 83 (05) :525-529
[6]   CHARACTERIZATION OF A NOVEL PROTEIN REGULATED DURING THE CRITICAL PERIOD FOR SONG LEARNING IN THE ZEBRA FINCH [J].
GEORGE, JM ;
JIN, H ;
WOODS, WS ;
CLAYTON, DF .
NEURON, 1995, 15 (02) :361-372
[7]   Dementia with Lewy bodies [J].
Gómez-Tortosa, E ;
Ingraham, AO ;
Irizarry, MC ;
Hyman, BT .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (11) :1449-1458
[8]   Genetic classification of primary neurodegenerative disease [J].
Hardy, J ;
Gwinn-Hardy, K .
SCIENCE, 1998, 282 (5391) :1075-1079
[9]   Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro:: Relevance for Lewy body disease [J].
Hashimoto, M ;
Hsu, LJ ;
Sisk, A ;
Xia, Y ;
Takeda, A ;
Sundsmo, M ;
Masliah, E .
BRAIN RESEARCH, 1998, 799 (02) :301-306
[10]   AN EARLY CYTOPLASMIC CHANGE BEFORE LEWY BODY MATURATION - AN ULTRASTRUCTURAL-STUDY OF THE SUBSTANTIA-NIGRA FROM AN AUTOPSY CASE OF JUVENILE PARKINSONISM [J].
HAYASHIDA, K ;
OYANAGI, S ;
MIZUTANI, Y ;
YOKOCHI, M .
ACTA NEUROPATHOLOGICA, 1993, 85 (04) :445-448